Any process that activates or increases the frequency, rate, or extent of production of any member of the interleukin-17 family of cytokines.

The process in which a CD4-positive, alpha-beta T cell becomes committed to becoming a T-helper 17 cell, a CD4-positive, alpha-beta T cell with the phenotype RORgamma-t-positive that produces IL-17.

Any process that activates or increases the frequency, rate, or extent of production of any member of the interleukin-17 family of cytokines.

The process in which a CD4-positive, alpha-beta T cell becomes committed to becoming a T-helper 17 cell, a CD4-positive, alpha-beta T cell with the phenotype RORgamma-t-positive that produces IL-17.

The process in which a relatively unspecialized cell acquires the specialized features of a natural killer cell.

The expansion of a natural killer cell population by cell division.

Any process that activates or increases the frequency, rate, or extent of interferon-gamma production. Interferon-gamma is also known as type II interferon.

Any process that activates or increases the frequency, rate or extent of natural killer cell mediated cytotoxicity.

Any process that modulates the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus.

Reactions, triggered in response to the presence of a foreign body or the occurrence of an injury, which result in restriction of damage to the organism attacked or prevention/recovery from the infection caused by the attack.

The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via cell adhesion molecules.

The attachment of a plasma membrane adhesion molecule in one cell to an identical molecule in an adjacent cell.

The change in morphology and behavior of a natural killer cell in response to a cytokine, chemokine, cellular ligand, or soluble factor.

Any process that modulates the frequency, rate or extent of signaling in response to detection of lipopolysaccharide.

Any process that stops, prevents, or reduces the frequency, rate, or extent of granulocyte macrophage colony-stimulating factor production.

Any process that stops, prevents, or reduces the frequency, rate, or extent of granulocyte macrophage colony-stimulating factor production.

Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-18 production.

Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-18 production.

Any process that activates or increases the frequency, rate, or extent of interferon-gamma production. Interferon-gamma is also known as type II interferon.

Any process that modulates the frequency, rate or extent of natural killer cell activation.

Any process that stops, prevents, or reduces the frequency, rate, or extent of mast cell activation.

Any process that stops, prevents, or reduces the frequency, rate, or extent of mast cell activation.

The directed killing of a target cell by a natural killer cell through the release of granules containing cytotoxic mediators or through the engagement of death receptors.

Any process that modulates the frequency or rate of macrophage activation.

Any process that stops, prevents, or reduces the rate of mast cell degranulation.

Any process that stops, prevents, or reduces the rate of mast cell degranulation.

Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the MAPK cascade.

Any process that activates or increases the frequency, rate or extent of natural killer cell mediated cytotoxicity.

The movement of a leukocyte within or between different tissues and organs of the body.

Any process that activates or increases the frequency, rate or extent of activity of the transcription factor NF-kappaB.

Any process that activates or increases the frequency, rate, or extent of production of monocyte chemotactic protein-1.

Any process that stops, prevents or reduces the frequency, rate or extent of interleukin-6 secretion.

Any process that activates or increases the frequency, rate or extent of tumor necrosis factor secretion.

Any process that stops, prevents or reduces the frequency, rate or extent of interleukin-10 secretion.

Any process that modulates the frequency, rate or extent of store-operated calcium entry.

Any process that modulates the frequency, rate or extent of store-operated calcium entry.

The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.

The external part of the cell wall and/or plasma membrane.

The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).

The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).

The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.

The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface.

A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.